Recommendations for inclusion in the Authorisation List
Recommendations for inclusion in the Authorisation List
Applications imbriquées
The REACH Regulation requires that ECHA recommends from the "Candidate List" priority substances for inclusion in Annex XIV (the "Authorisation List") to the European Commission, taking into account comments received from interested parties and the opinion of the Member State Committee. The European Commission finally decides, which substances will be included in Annex XIV and what the associated entries will be.
The below table includes all Candidate List substances that have been included in ECHA's draft or final recommendations for inclusion in Annex XIV. The "Status"- column indicates whether the substances have been included in a draft recommendation, recommended for inclusion or are already included in Annex XIV. Further details and documents relevant for the recommendations can be found by clicking on the "Details" next to the substances.
Substances not recommended in a given round (Status: “Not recommended in this round”) are re-assessed in subsequent rounds along with the other substances on the Candidate List. They may be included in future recommendations. Therefore, it is advisable to search the table by substance (Name/EC/CAS) to capture the most up-to-date status.
- Consultation on draft recommendation for inclusion in the Authorisation List
- MSC recommendation opinions
- Recommendation for inclusion in the Authorisation List under the Legislation section
- Authorisation Process
- Recommendation to amend authorisation list entries
- Candidate List of SVHCs for authorisation
- Authorisation List
Recommendations for inclusion in the Authorisation List
Last updated 08 février 2024. Database contains 116 unique substances/entries.
232-143-1
|
7789-09-5
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) |
3rd recommendation
|
Included in Annex XIV (Authorisation List)
|
20-déc.-2011
|
Details | |
show/hide
|
-
|
-
|
Carcinogenic (Article 57a) |
3rd recommendation
|
Included in Annex XIV (Authorisation List)
|
20-déc.-2011
|
Details |
201-329-4
|
81-15-2
|
vPvB (Article 57e) |
1st recommendation
|
Included in Annex XIV (Authorisation List)
|
01-juin-2009
|
Details | |
covering any of the individual stereoisomers of [1] and [2] or any combination thereof
show/hide
1,3-Dioxane, 2-[(1S,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
EC No.:
-
| CAS No.:
676367-06-9
Reaction mass of 5-sec-butyl-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane and 5-sec-butyl-2-(4,6-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane
EC No.:
413-720-9
| CAS No.:
-
1,3-Dioxane, 2-(2,4-dimethyl-3-cyclohexen-1-yl)-5-methyl-5-(1-methylpropyl)-
EC No.:
601-499-3
| CAS No.:
117933-89-8
1,3-Dioxane, 2-(2,4-dimethyl-3-cyclohexen-1-yl)-5-methyl-5-(1-methylpropyl)-
EC No.:
-
| CAS No.:
186309-28-4
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
EC No.:
-
| CAS No.:
676367-05-8
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-rel-
EC No.:
-
| CAS No.:
343934-04-3
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
EC No.:
-
| CAS No.:
676367-09-2
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-rel-
EC No.:
-
| CAS No.:
343934-05-4
1,3-Dioxane, 2-[(1R,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
EC No.:
-
| CAS No.:
676367-04-7
1,3-Dioxane, 2-[(1R,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
EC No.:
-
| CAS No.:
676367-08-1
1,3-Dioxane, 2-[(1S,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
EC No.:
-
| CAS No.:
676367-03-6
1,3-Dioxane, 2-[(1S,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
EC No.:
-
| CAS No.:
676367-07-0
1,3-Dioxane, 2-[(1S,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
EC No.:
-
| CAS No.:
676367-02-5
|
-
|
-
|
vPvB (Article 57e) |
8th recommendation
|
Included in Annex XIV (Authorisation List)
|
05-févr.-2018
|
Details |
substances with a linear and/or branched alkyl chain with a carbon number of 9 covalently bound in position 4 to phenol, ethoxylated covering UVCB- and well-defined substances, polymers and homologues, which include any of the individual isomers and/or combinations thereof
show/hide
26-(4-Nonylphenoxy)-3,6,9,12,15,18,21,24- octaoxahexacosan -1-ol
EC No.:
604-395-6
| CAS No.:
14409-72-4
Nonylphenol, branched, ethoxylated
1 - 2.5 moles ethoxylated
EC No.:
500-209-1
| CAS No.:
68412-54-4
Poly (oxy-1,2-ethanediyl), alpha -(nonylphenyl)-omega-hydroxy-, branched
EC No.:
932-337-2
| CAS No.:
-
44-(nonylphenoxy)-3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaoxatetratetracontanol
EC No.:
260-678-0
| CAS No.:
57321-10-5
4-Nonylphenol, branched, ethoxylated
1 - 2.5 moles ethoxylated
EC No.:
500-315-8
| CAS No.:
127087-87-0
3,6,9,12,15,18,21,24,27-Nonaoxanonacosan-1-ol, 29-(isononylphenoxy)-
EC No.:
-
| CAS No.:
65455-72-3
29-(nonylphenoxy)-3,6,9,12,15,18,21,24,27-nonaoxanonacosanol
EC No.:
248-294-1
| CAS No.:
27177-08-8
26-(nonylphenoxy)-3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol
EC No.:
247-816-5
| CAS No.:
26571-11-9
26-(nonylphenoxy)-3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol
EC No.:
255-695-5
| CAS No.:
42173-90-0
3,6,9,12-Tetraoxatetradecan-1-ol, 14-(4-nonylphenoxy)-, branched
EC No.:
293-926-1
| CAS No.:
91648-64-5
|
799-990-1
|
-
|
Endocrine disrupting properties (Article 57(f) - environment) |
6th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-juil.-2015
|
Details |
covering well-defined substances and UVCB substances, polymers and homologues
show/hide
Poly(oxy-1,2-ethanediyl), α-[(1,1,3,3-tetramethylbutyl)phenyl]-ω-hydroxy-
EC No.:
618-541-1
| CAS No.:
9036-19-5
20-[4-(1,1,3,3-tetramethylbutyl)phenoxy]-3,6,9,12,15,18-hexaoxaicosan-1-ol
EC No.:
219-682-8
| CAS No.:
2497-59-8
|
799-991-7
|
-
|
Endocrine disrupting properties (Article 57(f) - environment) |
5th recommendation
|
Included in Annex XIV (Authorisation List)
|
06-févr.-2014
|
Details |
202-974-4
|
101-77-9
|
Carcinogenic (Article 57a) |
1st recommendation
|
Included in Annex XIV (Authorisation List)
|
01-juin-2009
|
Details | |
202-918-9
|
101-14-4
|
Carcinogenic (Article 57a) |
4th recommendation
|
Included in Annex XIV (Authorisation List)
|
17-janv.-2013
|
Details | |
209-218-2
|
561-41-1
|
Carcinogenic (Article 57a) |
9th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-oct.-2019
|
Details | |
239-622-4
|
15571-58-1
|
Toxic for reproduction (Article 57c) |
9th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-oct.-2019
|
Details | |
223-346-6
|
3846-71-7
|
PBT (Article 57d) vPvB (Article 57e) |
8th recommendation
|
Included in Annex XIV (Authorisation List)
|
05-févr.-2018
|
Details | |
253-037-1
|
36437-37-3
|
vPvB (Article 57e) |
8th recommendation
|
Included in Annex XIV (Authorisation List)
|
05-févr.-2018
|
Details | |
247-384-8
|
25973-55-1
|
PBT (Article 57d) vPvB (Article 57e) |
8th recommendation
|
Included in Annex XIV (Authorisation List)
|
05-févr.-2018
|
Details | |
204-450-0
|
121-14-2
|
Carcinogenic (Article 57a) |
2nd recommendation
|
Included in Annex XIV (Authorisation List)
|
17-déc.-2010
|
Details | |
223-383-8
|
3864-99-1
|
vPvB (Article 57e) |
8th recommendation
|
Included in Annex XIV (Authorisation List)
|
05-févr.-2018
|
Details | |
203-445-0
|
106-94-5
|
Toxic for reproduction (Article 57c) |
6th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-juil.-2015
|
Details | |
203-458-1
|
107-06-2
|
Carcinogenic (Article 57a) |
4th recommendation
|
Included in Annex XIV (Authorisation List)
|
17-janv.-2013
|
Details | |
284-032-2
|
84777-06-0
|
Toxic for reproduction (Article 57c) |
6th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-juil.-2015
|
Details | |
271-093-5
|
68515-50-4
|
Toxic for reproduction (Article 57c) |
7th recommendation
|
Included in Annex XIV (Authorisation List)
|
10-nov.-2016
|
Details | |
271-084-6
|
68515-42-4
|
Toxic for reproduction (Article 57c) |
6th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-juil.-2015
|
Details | |
276-158-1
|
71888-89-6
|
Toxic for reproduction (Article 57c) |
6th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-juil.-2015
|
Details | |
with ≥ 0.3% of dihexyl phthalate (EC No. 201-559-5)
show/hide
1,2-Benzenedicarboxylic acid, mixed decyl and hexyl and octyl diesters
EC No.:
272-013-1
| CAS No.:
68648-93-1
|
-
|
-
|
Toxic for reproduction (Article 57c) |
8th recommendation
|
Included in Annex XIV (Authorisation List)
|
05-févr.-2018
|
Details |